Asthma, Glucocorticoids and Growth

References

• Teitelbaum S L. Skeletal growth, and development. Primer on the metabolic bone diseases and disorders of mineral metabolism, M J. Favus. Kelseyville, CaliforniaAmerican Society for Bone and Mineral Disease. 1990; 7–11
   Google Scholar
• Termine J D. Bone Matrix proteins, and the mineralization process. Primer on the metabolic bone diseases and disorders of mineral metabolism, M J. Favus. American Society for Bone and Mineral Disease, Kelseyville, California 1990; 16–18
   Google Scholar
• Canalis E. Regulation of bone remodeling. Primer on the metabolic bone diseases and disorders of mineral metabolism, M J. Favus. American Society for Bone and Mineral Disease, Kelseyville, California 1990; 22–26
   Google Scholar
• Hindmarsh P C., Brook C GD. Normal growth and its endocrine control. Clinical paediatric endocrinology, C GD Brook. Blackwell Scientific Publications, Oxford 1989; 57–69
   Google Scholar
• Karlberg J, Engstrom I, Karlberg P, Fryer J G. Analysis of linear growth using a mathematical model I. From birth to three years. Acta Paediatr Scand 1987; 76: 478–88
   PubMed Web of Science ®Google Scholar
• Hill D J., Milner R DG. Mechanism of fetal growth. Clinical paediatric endocrinology, C GD Brook. Black‐well Scientific Publications, Oxford 1989; 3–31
   Google Scholar
• Lew L Q., Sklar C A., Yoon D J., David R. Adrenal androgens in children with short stature. Horm Res 1988; 29: 151–5
   Google Scholar
• Hindmarsh P C., Crowley S, Brook C GD. Effects of asthma and asthma treatment on children's growth. Eur Resp Rev 1993; 3(13)313–6
   Google Scholar
• Zeitlin S R., Crowley S, Hindmarsh P C., Brook C GD. Inhaled corticosteroids and growth. Eur Resp Rev 1993; 13: 333–7
   Google Scholar
• Pedersen S. Safety aspects of corticosteroids in children. Eur Resp Rev 1994; 4(17)33–43
   Google Scholar
• Hauspie R, Crowley S, Alexander F. Maturational delay and temporal growth retardation in asthmatic boys. J Allergy Clin Immunol 1977; 59: 200–6
   PubMed Web of Science ®Google Scholar
• Martin A, Landau L, Phelan P. The effect on growth of childhood asthma. Acta Paediatr Scand 1981; 70: 683–8
   PubMedGoogle Scholar
• Kallenbach J M., Panz V, Girson M S., Joffe B I., Seftel H C. The hormonal response to exercise in asthma. Eur Respir J 1990; 3: 171–5
   Google Scholar
• Shohat M, Shohat T, Kedem R, Mimouni M, Danon Y L. Childhood asthma and growth outcome. Arch Dis Child 1987; 62: 63–5
   PubMed Web of Science ®Google Scholar
• Priftis K, Milner A D., Conway E, Honour J W. Adrenal function in asthma. Arch Dis Child 1990; 65: 838–40
   PubMed Web of Science ®Google Scholar
• Ferguson A C., Murray A B. Short stature and delayed skeletal maturation in children with allergic disease. J Allergy Clin Immunol 1982; 69: 461–6
   PubMedGoogle Scholar
• Massarano A A., Hollis S, Devlin J, David T J. Growth in atopic eczema. Arch Dis Child 1993; 68: 677–9
   PubMed Web of Science ®Google Scholar
• Klein G L., Dungy C I., Galant S P. Growth and the nutritional status of nonsteroid‐dependent asthmatic children. Ann Allergy 1991; 67: 80–4
   Google Scholar
• Hermanussen M, Geiger‐Benoit K, Burmeister J, Sippell W. Knemometry in childhood; accuracy and standardization of a new technique of lower leg length measurement. Ann Hum Biol 1988; 15: 1–16
   PubMed Web of Science ®Google Scholar
• Hermanussen M, Geiger‐Benoit K, Burmeister J, Sippell W. Periodical changes of short‐term growth velocity ('mini growth spurts') in human growth. Ann Hum Biol 1988; 15: 103–9
   PubMed Web of Science ®Google Scholar
• FleischerMichaelsen K, Skov L, Badsberg J H., Jorgensen M. Short‐term measurement of linear growth in preterm infants: validation of a hand‐held knemometer. Pediatr Res 1991; 30: 464–8
   Google Scholar
• Wales J KH, Milner R DG. Knemometry in the assessment of linear growth. Arch Dis Child 1987; 62: 166–71
   PubMed Web of Science ®Google Scholar
• Schiele F, Henny J, Hitz Petitclerc C, Gueguen R, Siest G. Total bone and liver alkaline phosphatases in plasma: Biological variations and reference limits. Clin Chem 1983; 29: 634–41
   PubMed Web of Science ®Google Scholar
• Price P A., Parthermore J G., Deftos L J. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone gla protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980; 66: 878–83
   PubMed Web of Science ®Google Scholar
• Gundberg C M., Lian J B., Gallop P M. Measurements of gamma‐carboxyglutamate and circulating osteocalcin in normal children and adults. Clin Chim Acta 1983; 128: 1–8
   PubMed Web of Science ®Google Scholar
• Perez A, Praet J P., Bosson D, Rozenberg S, Bourdoux P. Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment. J Rheumatol 1989; 16: 363–7
   Google Scholar
• Ekenstam E, Stålenheim G, Hällgren R. The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism 1988; 37: 141–4
   PubMed Web of Science ®Google Scholar
• Tarallo P, Henny J, Fournier B, Siest G. Plasma osteocalcin: biological variations and reference limits. Scand J Clin Lab Invest 1990; 50: 649–55
   PubMed Web of Science ®Google Scholar
• Sidenius Johansen J, Giwercman A, Hartwell D, et al. Serum Bone Gla‐protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin‐like growth factor I, and serum testosterone. J Clin Endocrinol Metab 1988; 67: 273–8
   Google Scholar
• Southard R N., Morris J D., Mahan J D., et al. Bone mass in healthy children: Measurement with quantitative DXA. Radiology 1991; 179: 735–8
   PubMed Web of Science ®Google Scholar
• Prockop D J., Kivirikko Kl, Tuderman L, Guzman N A. The biosynthesis of collagen and its disorders. N Engl J Med 1979; 301: 13–23
   PubMed Web of Science ®Google Scholar
• Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990; 36: 1328–32
   PubMed Web of Science ®Google Scholar
• Trivedi P, Risteli J, Risteli L, Hindmarsh P C., Brook C GD, Mowat A P. Serum concentration of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 1991; 30: 276–80
   PubMed Web of Science ®Google Scholar
• Saggese G, Bertelloni, Baroncelli Gl, DiNero G. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr 1992; 151: 764–8
   PubMedGoogle Scholar
• Eriksen E F., Charles P, Melsen F, Mosekilde L, Risteli L. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with histo‐morphometry. J Bone Miner Res 1993; 8: 127–32
   PubMed Web of Science ®Google Scholar
• Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L, Risteli J. Radioimmunoassay for the pyridinoline cross‐linked carboxy‐terminal telopeptidedegradation in metabolic bone disease: correlation with bone of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635–40
   PubMed Web of Science ®Google Scholar
• Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat A P., Risteli L. Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–8
   PubMed Web of Science ®Google Scholar
• Hyams J S., Treem W R., Carey D E., et al. Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease. Gastroenterology 1991; 100: 9715
   Google Scholar
• Seyedin S M., Kung V T., Daniloff Y N., et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993; 8: 635–41
   PubMed Web of Science ®Google Scholar
• Miesfeld R L. Molecular genetics of corticosteroid action. Am Rev Respir Dis 1990; 141: 11–7, (S)
   PubMed Web of Science ®Google Scholar
• McCarthy T L., Centrell M, Canalis E. Cortisol inhibits the synthesis of insulin‐like growth factor‐l in skeletal cells. Endocrinology 1990; 126: 1569–75
   PubMed Web of Science ®Google Scholar
• Unterman T G., Phillips L S. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 1985; 61: 618–26
   Google Scholar
• Hahn T J. Steroid, and drug‐induced osteopenia. Primer on the metabolic bone diseases and disorders of mineral metabolism, M J. Favus. American Society for Bone and Mineral Disease, Kelseyville, California 1990; 158–62
   Google Scholar
• Smith R. Corticosteroids and osteoporosis. Thorax 1990; 45: 573–8
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Sorva R, Juntunen‐Backman K. Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. J Allergy Clin Immunol 1991; 88: 384–9
   PubMed Web of Science ®Google Scholar
• Tinkelman D G., Reed C E., Nelson H S., Offord K P. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92: 64–77
   PubMed Web of Science ®Google Scholar
• Sorva R, Turpeinen M, Juntunen‐Backman K, Karonen S ‐L, Sorva A. Effect of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 1992; 90: 808–15
   PubMedGoogle Scholar
• Blodgett F M., Burgin L, lezzoni D, Gribetz D, Talbot E B. Effects of prolonged cortisone therapy on statural growth, skeletal maturation and metabolic status of children. N Engl J Med 1956; 254: 636–41
   PubMed Web of Science ®Google Scholar
• Kerrebjin K F., de Kroon J P. Effect on height of glucocorticoid therapy in asthmatic children. Arch Dis Child 1968; 43: 556–613
   Google Scholar
• Oberger E, Engström I, Karlberg J. Long‐term treatment with glucocorticoids/ACTH asthmatic children. Acta Paediatr Scand 1990; 79: 77–83
   Google Scholar
• Relmer L G., Morris H G., Ellis E F. Growth of asthmatic children during treatment with alternate day steroids. J Allergy Clin Immunol 1975; 55: 224–31
   Google Scholar
• Nassif E, Weinburger M, Serman B, et al. Extrapulmonary effects of maintenance corticosteroid therapy with alternate day prednisolone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1987; 80: 518–29
   PubMed Web of Science ®Google Scholar
• Van Metre T E., Pinkerton H L. Growth suppression in asthmatic children receiving prolonged therapy with prednisone and methylprednisolone. J Allergy 1959; 30: 103–13
   Google Scholar
• Wales J KH, Milner R DG. Variation in lower leg growth with alternate day steroid treatment. Arch Dis Child 1988; 63: 981–3
   PubMed Web of Science ®Google Scholar
• Wolthers O D., Pedersen S. Short‐term growth in asthmatic children during treatment with prednisolone. BMJ 1990; 301: 145–8
   PubMed Web of Science ®Google Scholar
• Wolthers O D., Pedersen S. Growth of asthmatic children during treatment with budesonide: a double‐blind trial. BMJ 1991; 303: 163–5
   PubMed Web of Science ®Google Scholar
• Mackenzie C A., Wales J KH. Growth of asthmatic children. BMJ 1991; 303: 416
   Google Scholar
• Morrow Brown H, Storey G. Beclomethasone dipropionate steroid aerosol in treatment of perennial allergic asthma in children. BMJ 1973; 3: 161–4
   Google Scholar
• Brown D CP, Savacool A M., Letizla C M. A retrospective review of the effects of one year of triamcinolone acetonide aerosol treatment on the growth pattern of asthmatic children. Ann Allergy 1989; 63: 47–51
   Google Scholar
• Godfrey S, Konlg P. Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol. Arch Dis Child 1974; 49: 591–6
   PubMedGoogle Scholar
• Godfrey S, Balfour‐Lynn L, Tooley M. A three to five year follow‐up of the use of the aersosol steroid, beclomethasone dipropionate in childhood asthma. J Allergy Clin Immunol 1978; 62: 335–9
   PubMed Web of Science ®Google Scholar
• Graff‐Lonnevlg V, Kraepelien S. Long‐term treament with beclomethasone dipropionate aerosol in asthmatic children with special reference to growth. Allergy 1979; 34: 57–61
   Google Scholar
• Balfour‐Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61: 335–9
   Google Scholar
• Littlewood J M., Johnson A W., Edwards P A., Littlewood A E. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet 1988; 34: 57–61
   Google Scholar
• Delacourt C, Chomienne F, de Blic J, et al. Preservation of growth velocity in asthmatic children treated with high doses of inhaled beclomethasone dipropionate. Eur Respir J 1991; 4(Supp 1)1429
   Google Scholar
• Varsano I, Volowitz B, Malik H, et al. Safety of 1 year treatment with inhaled budesonide in young children with asthma. J Allergy Clin Immunol 1990; 85: 914–20
   PubMed Web of Science ®Google Scholar
• Volovftz B, Amir J, Malik H, Kauschansky A, Varsano I. Growth and pituitary‐adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 1993; 329: 1703–8
   Google Scholar
• Bisgaard H. Systemic activity of inhaled topical steroid in toddlers studied by knemometry. Acta Paediatr Scand 1993; 82: 1066–71
   PubMed Web of Science ®Google Scholar
• Ninan T K., Russell G. Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child 1992; 67: 703–5
   PubMedGoogle Scholar
• Allen D B., Goldberg B D. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid‐treated children. Pediatrics 1992; 89: 416–21
   PubMed Web of Science ®Google Scholar
• Reid I R., Chapman G E., Fraser T RC, et al. Low serum osteocalcin levels in glucocorticoid‐treated asthmatics. J Clin Endocrinol Metab 1986; 62: 379–83
   PubMed Web of Science ®Google Scholar
• Reid D M., Nicoll J J., Smith M A., Higgins B, Tothlll P, Nuki G. Corticosteroids and bone mass in asthma: comparison with rheumatoid arthritis and polymyalgia rheumatica. BMJ 1986; 293: 1463–6
   PubMedGoogle Scholar
• Könlg P, Hillman L, Cervantes C I. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Paediatr 1993; 122: 219–26
   Google Scholar
• Puolijokl H, Liippo K, Herrala J, Salmi J, Tala E. Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic women. Sone 1992; 13: 285–8
   Google Scholar
• Leech J A., Hodder R V., Ooi D S., Gay J. Effects of short‐term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Respir Dis 1993; 148: 113–5
   Google Scholar
• Jennings B H., Andersson K E., Johansson S Å. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1991; 40: 77–82
   PubMed Web of Science ®Google Scholar
• Hodsman A B., Toodgood J H., Jennings B H., Fraher L J., Baskerville J C. Differential effects of inhaled beudesonide and oral prednisolone on serum osteocalcin. J Allergy Clin Immunol 1991; 72: 530–40
   Google Scholar
• Toogood J H., Sorva R, Puolijokl H. Review of the effects inhaled steroid therapy on bone. International workshop. 'Risk and safety of asthma therapy'. Journal of Risk and Safety in Medicine 1994, (in press)
   Google Scholar
• Wolff A H., Adelsberg B, Aloia J, Zitt M. Effect of inhaled corticosteroid on bone density in asthmatic patients: a pilot study. Ann Allergy 1991; 67: 117–21
   PubMedGoogle Scholar
• Luengo M, DelRio L, Guanabens N, et al. Long‐term effect of oral and inhaled glucocorticoids on bone mass in chronic asthma. A two‐year follow‐up study. Eur Respir J Suppl 1991; 4: 342S
   Google Scholar
• Packe G E., Douglas J G., McDonald A F., Robins S P., Reid D M. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992; 47: 415–7
   Web of Science ®Google Scholar
• Sorva R, Juntunen‐Backman K, Turpeinen M, Komulainen J. Bone mineral density in asthmatic children treated with corticosteroids. Allergy 1993; 48(16S)28
   Google Scholar
• Szefler S J. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991; 88: 147–65
   PubMed Web of Science ®Google Scholar
• Barnes P J., Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148: S1–26
   PubMed Web of Science ®Google Scholar
• Hollman G A., Allen D B. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 1988; 81: 452–5
   PubMed Web of Science ®Google Scholar
• Priftis K, Everard M L., Milner A D. Unexpected side‐effects of inhaled steroids: a case report. Eur J Pediatr 1991; 150: 448–9
   Google Scholar